Features July 2014 Issue

FDA Says Fewer People Should Take Daily Aspirin

Bleeding risks may outweigh the preventive benefits for those without heart disease.

Taking a daily aspirin to help prevent a heart attack has been standard advice for just about anybody considered at risk for heart disease. But recently the U.S. Food and Drug Administration (FDA) issued a recommendation that essentially says daily aspirin therapy is only for individuals with diagnosed cardiovascular problems. The FDA argues that research hasnít proven a benefit for people without cardiovascular disease. The report contends that having a risk factor, such as family history of heart disease, isnít enough to risk the potential bleeding problems associated with aspirin use.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.